2009
DOI: 10.1016/j.canlet.2009.07.013
|View full text |Cite
|
Sign up to set email alerts
|

Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
59
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 70 publications
(62 citation statements)
references
References 71 publications
3
59
0
Order By: Relevance
“…37,38 Genotype D is the most common genotype in HBVassociated HCC as reported from different series. 39 The b-catenin pathway appears not to be significantly involved in HBV-related HCC in India. The very low frequency of TP53 mutation suggests low levels of Aflatoxin B1 exposure.…”
Section: Are Indians Genetically More Prone To Hepatocellular Carcinoma?mentioning
confidence: 95%
“…37,38 Genotype D is the most common genotype in HBVassociated HCC as reported from different series. 39 The b-catenin pathway appears not to be significantly involved in HBV-related HCC in India. The very low frequency of TP53 mutation suggests low levels of Aflatoxin B1 exposure.…”
Section: Are Indians Genetically More Prone To Hepatocellular Carcinoma?mentioning
confidence: 95%
“…Of the eight genotypes discovered, genotypes B and C are prevalent in Asia, while genotypes A and D are prevalent in Europe, United States and Central Africa (Pujol et al, 2009). Four genotypes have been observed in China mainland and genotype B and C accounts for 95%.…”
Section: Hepatitis Viral Infectionmentioning
confidence: 99%
“…HBV genotype F was associated to a higher frequency of HCC development at younger age in Alaskan individuals (Livingston et al, 2007). However, the risk of HCC may differ among subgenotypes (Pujol et al, 2009). Fig.…”
Section: Hbvmentioning
confidence: 85%
“…The selection of the G1896A seems to be genotype-dependent (Devesa & Pujol, 2007). The basal core promoter overlaps with the X region of the HBV genome, and mutations in the amino acid sequences at positions 130 and 131 in this region (K130M and V131I) has been proposed as prognostic markers for the development of liver cancer (Kuang et al, 2004, Pujol et al, 2009). Some genotypic variability may also occur in terms of interferon sensitivity and development of drug resistance Ramos et al, 2007).…”
Section: Hbvmentioning
confidence: 99%